<乌鸦传媒>Biden Admin Imposes National Limits on 'Forever Chemicals' in Drinking Water Most important action the EPA has ever taken on PFAS, says agency administrator Apr 10, 2024
<乌鸦传媒>Cancer Warnings on Booze; Rats, Roaches in Hospitals; Barefoot Pharma Workers Health news and commentary from around the Web gathered by 乌鸦传媒 staff Apr 10, 2024
<乌鸦传媒>Accelerated Aging Linked to Recent Increase in Early-Onset Solid Tumors Strength of association increased in more recent birth cohorts Apr 09, 2024
<乌鸦传媒>Novel PARP1 Inhibitor Shows Promise in Breast Cancer The drug had favorable safety compared with first-generation PARP inhibitors in phase I/II study Apr 09, 2024
<乌鸦传媒>Can Late-Stage Cancer Incidence Serve as an Endpoint for Screening Trials? Study shows it may be an alternative to cancer-specific mortality for some cancers, but not all Apr 08, 2024
<乌鸦传媒>Most Cancer Drugs Granted Accelerated Approval Fail Confirmatory Trials Only 43% showed clinical benefit within 5 years Apr 08, 2024
<乌鸦传媒>Enhertu Gets Tumor-Agnostic FDA Approval for HER2-Positive Cancers About half of patients responded, duration of response as long as 19 months in three trials Apr 05, 2024
<乌鸦传媒>Cancer 'Tidal Wave' Forecast; Not Decaf, Too! Cautionary Tales of Cancer, Cannabis News, features, and commentary about cancer-related issues Apr 05, 2024
<乌鸦传媒>Incorporating Bereavement Into the Continuum of Care "Poor cousin of palliative care" needs more resources, buy-in, and normalization Apr 04, 2024
<乌鸦传媒>Chemotherapy/ICI Combos Falter as Second-Line Treatment for Gastric Cancer FOLFIRI plus durvalumab, with or without tremelimumab, no help after first-line chemotherapy Apr 04, 2024
<乌鸦传媒>Patient Stabs ED Worker; Campus Building Tied to Cancer; Your Gut and Heart Disease Health news and commentary from around the Web gathered by 乌鸦传媒 staff Apr 03, 2024
<乌鸦传媒>Microwave Ablation a Safer Option for Multifocal Papillary Thyroid Carcinoma? Observational study suggests promising benefits of skipping surgery Apr 02, 2024
<乌鸦传媒>Some Cancer Patients Can Find It Hard to Tell Family and Friends Recent high-profile examples highlight this reluctance Mar 31, 2024
<乌鸦传媒>The Cancer Journey Is Not Unique to the Royals The U.S. needs a more human-centric care approach for all patients Mar 29, 2024
<乌鸦传媒>Chemo and Heart Disease; Flawed Lung Cancer Screening; New Vax Recommendations News, features, and commentary about cancer-related issues Mar 29, 2024
<乌鸦传媒>Oncologists Express Conflicted Views About AI in Clinical Practice Uncertainty about how the technology may fit with practice standards, medico-legal environment Mar 28, 2024
<乌鸦传媒>CDC: Latest COVID Vax Cuts Hospitalization Risk in Immunocompromised People But fewer than one in five of this vulnerable group have received the updated shot Mar 28, 2024
<乌鸦传媒>Death Is Inevitable. Doctors Should Be Prepared to Manage It Appropriately. End-of-life communication is a skill that must be practiced and honed Mar 28, 2024
<乌鸦传媒>Kate Middleton's Cancer: What to Know About 'Preventative' Chemotherapy And what abdominal surgery could mean in the context of cancer Mar 26, 2024
<乌鸦传媒>Reconsider Insertion of Abdominal Drains After Distal Pancreatectomy, Study Suggests Rate of major morbidity was non-inferior in the no-drain group compared with the drain group Mar 25, 2024
<乌鸦传媒>Graphic Images on Cigarettes of Smoking's Harm Are Constitutional, Court Rules Partial victory for federal regulators seeking to toughen warning labels Mar 22, 2024
<乌鸦传媒>Broader Cancer Risk With CAR-T? AI for Physician Burnout; 'Lollipops' ID Oral Cancer News, features, and commentary about cancer-related issues Mar 22, 2024
<乌鸦传媒>No OS Difference in Pancreatic Cancer With SABR vs Irreversible Electroporation PFS, adverse events also comparable with the ablative modalities after FOLFIRINOX chemotherapy Mar 21, 2024
<乌鸦传媒>Child Deaths Rise in U.S.; Water Beads Warning; Cancer Studies Retracted Health news and commentary from around the Web gathered by 乌鸦传媒 staff Mar 21, 2024
<乌鸦传媒>Who Should Pay to Clean Up 'Forever Chemicals'? Not us, representatives of water utilities and landfills say at a Senate hearing Mar 20, 2024
<乌鸦传媒>Lenvatinib-Pembrolizumab Combo Misses on Survival in Endometrial Cancer Trial Combination in first-line fails to improve progression-free, overall survival versus chemotherapy Mar 20, 2024
<乌鸦传媒>Rucaparib Maintenance Boosts PFS in Metastatic, Recurrent Endometrial Cancer Use of the PARP inhibitor improved PFS by 19.4 months versus placebo in phase II study Mar 19, 2024
<乌鸦传媒>EPA Bans Asbestos, a Deadly Carcinogen Still in Use Decades After Partial Ban New rule would prohibit chrysotile asbestos Mar 19, 2024
<乌鸦传媒>How Often Should Immunocompromised People Get a COVID Booster? Experts say about every 6 months, but that should be individualized Mar 18, 2024
<乌鸦传媒>Gynecologic Oncology May Face a Future of Too Few Cases, Too Many Docs Subspecialists could see only one patient a week with a new cancer diagnosis, researcher says Mar 18, 2024
<乌鸦传媒>Immune Checkpoint Inhibitor-Chemo Combo Boosts OS in Advanced Endometrial Cancer Dostarlimab and pembrolizumab regimens should be incorporated into practice "as of yesterday" Mar 17, 2024
<乌鸦传媒>EPA Imposes New Limit on Medical Sterilization Chemical, Citing Cancer Risk Rule would lower emission standards for ethylene oxide by 90%, agency says Mar 15, 2024
<乌鸦传媒>New PD-1 Inhibitor Approved for Esophageal Cancer Tislelizumab improved median OS from 6.3 months with chemotherapy to 8.6 months Mar 15, 2024
<乌鸦传媒>FDA Panel Endorses Imetelstat for MDS-Related Anemia By 12-2 vote, members find improvement in transfusion independence outweighs risk Mar 14, 2024
<乌鸦传媒>Getting Prostate Cancer Drugs Sooner; Limiting Toxic Emissions; FTC Sues 'Charity' News, features, and commentary about cancer-related issues Mar 14, 2024
<乌鸦传媒>FDA Staff Cast Doubt on Novel Drug for MDS-Related Anemia Agency asking its advisors if benefits outweigh risks for patients who fail on standard treatment Mar 12, 2024
<乌鸦传媒>Banning Gain-of-Function Research Would Do Far More Harm Than Good A House-passed bill could stifle the potential for revolutionary medical advancements Mar 11, 2024
<乌鸦传媒>First-Line Nivolumab Plus Chemo Approved for Bladder Cancer Combination reduced risk of death by 22% Mar 07, 2024
<乌鸦传媒>A Blenrep Comeback? Cancer Vaccine for Dogs; U.K. Snubs Enhertu News, features, and commentary about cancer-related issues Mar 07, 2024
